Fiercehealthcare iconFiercehealthcareSep 16, 2026 ~2 min source read

SCAN Health Plan and Walmart launch co-branded Medicare Advantage plans in two states, pending approvals

SCAN and Walmart announced a partnership to offer co-branded Medicare Advantage products tied to Walmart’s retail services and technology. Initial offerings will be limited and require regulatory review before launch.

Share this story

Send the public story page.

Useful takeaways from this story.

SCAN and Walmart plan to offer a co-branded Medicare Advantage plan initially in two states, with additional Medicare supplement coverage discussed in related SCAN partnerships.

Planned benefits may include pharmacy, vision, food and over‑the‑counter (OTC) benefits, and use of Walmart’s Everyday Health Signals platform for personalized wellness insights, all subject to regulatory approval.

SCAN Health Plan and Walmart announced a collaboration to launch a co-branded Medicare Advantage offering in two states. The companies say the plans will link SCAN's Medicare experience with Walmart's retail health services and technology. The announcement frames the partnership as an effort to make health services more connected to everyday consumer routines.

The companies specified potential components that would require regulatory review and approval before becoming available to members. Those components include:

  • Pharmacy services.
  • Vision services.
  • Food and over‑the‑counter benefits.
  • Use of Walmart's Everyday Health Signals platform to surface personalized wellness insights for members who opt in.

SCAN: The nonprofit health plan will supply Medicare product design, care experience knowledge, and member management capabilities. SCAN's national general manager, Zack Myers, framed the collaboration around personalization and data use: "At SCAN, we believe healthcare is better when it is personalized to the individual, and when members choose to opt in, data can help us deliver a more relevant experience tailored to their needs."

Walmart: Walmart will provide retail‑level access to pharmacy, vision, food and other health and wellness services, plus technology and data capabilities tied to Everyday Health Signals. Pravene Nath, Walmart U.S. Group Director for Consumer Health and Data Solutions, said Walmart has helped customers navigate Medicare choices for more than a decade and highlighted Walmart's frequent role in customers' everyday lives as a differentiator.

The companies emphasized that all offerings are pending regulatory review and approvals. The initial announcement covers a Medicare Advantage plan in two states. No launch dates, specific state names, enrollment windows, premiums, or benefit levels were provided in the announcement.

SCAN has recently announced other retail partnerships. Notably, SCAN expanded a partnership with Costco earlier in the year that included Medicare Advantage products across select states and a Medicare supplement option in another state. That move followed a trend of retail brands exploring deeper roles in Medicare products by pairing their customer reach with insurer capabilities.

If regulators approve the plan design, participating Medicare beneficiaries could see benefit packages that integrate retail services and personalized guidance tied to everyday shopping and pharmacy use. The proposed structure is positioned to make nutrition and routine care more reachable through retailers members already visit. Participation in data‑driven personalization features would be optional, according to SCAN's statement about opt‑in data use.

The SCAN–Walmart collaboration aims to combine SCAN's Medicare expertise with Walmart's retail footprint and data tools to create co‑branded Medicare Advantage offerings. Key details—states served, benefit specifics, costs, and launch timing—remain subject to regulatory approval and further company disclosures.

More context around this story.

Walmart Illegal Opioid Prescriptions
Tulsatoday iconTulsatodaySep 1, 2026

Walmart Illegal Opioid Prescriptions

The Justice Department, together with the Drug Enforcement Administration (DEA), Friday August 28, announced a $50 million settlement with Walmart Inc. (Walmart) to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app